| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/30/2010 | CA2754670A1 Anti-influenza formulations and methods |
| 09/29/2010 | EP2233437A1 Nanofunctional silica particles and manufacturing method thereof |
| 09/29/2010 | EP2233155A2 Therapeutic polyanhydride compounds for drug delivery |
| 09/29/2010 | EP2233144A1 Chitosan-containing compositions and process for production thereof |
| 09/29/2010 | EP2233142A1 Transdermally absorptive preparation |
| 09/29/2010 | EP2233141A1 Ppharmaceutical compositions coprising polymorphic forms of dehydroepiandrosterone |
| 09/29/2010 | EP2233139A1 Minoxidil aqueous composition containing bile acid |
| 09/29/2010 | EP2233138A1 Tape preparation comprising etodolac in ionic liquid form |
| 09/29/2010 | EP2233134A1 Multi-portion intra-oral dosage form with organoleptic properties |
| 09/29/2010 | EP2233133A1 Stable Rosuvastatin Compositions |
| 09/29/2010 | EP2233131A1 Pharmaceutical composition containing levodopa, entacapone and carbidopa |
| 09/29/2010 | EP2233130A1 A sustained release oral composition of an antipsychotic agent |
| 09/29/2010 | EP2233129A1 Oral cavity disintegrating tablet and method of producing the same |
| 09/29/2010 | EP2233112A2 Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin |
| 09/29/2010 | EP2231765A2 Polysaccharide nanoparticles |
| 09/29/2010 | EP2231588A1 Organic salts of -alanine |
| 09/29/2010 | EP2231257A1 Coating method |
| 09/29/2010 | EP2231193A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 09/29/2010 | EP2231192A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 09/29/2010 | EP2231191A2 Formulation of insulinotropic peptide conjugates |
| 09/29/2010 | EP2231189A1 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 09/29/2010 | EP2231188A2 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 09/29/2010 | EP2231175A2 Protein formulations and methods of making same |
| 09/29/2010 | EP2231144A2 Nanodispersion |
| 09/29/2010 | EP2231138A1 Oral pharmaceutical suspension comprising paracetamol and ibuprofen |
| 09/29/2010 | EP2231134A1 Biocompatible and biodegradable biopolymer matrix |
| 09/29/2010 | EP2231133A2 Method and compositions for administering resveratrol and pterostilbene |
| 09/29/2010 | EP2231132A2 Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof |
| 09/29/2010 | EP2231131A2 Formulations of organo-platinic compounds in the presence of associative polymers, products thus obtained and uses thereof |
| 09/29/2010 | EP2231130A1 Formulations comprising exine shells |
| 09/29/2010 | EP2231129A1 Therapeutic regimens for the treatment of immunoinflammatory disorders |
| 09/29/2010 | EP2231128A1 Method of treating dysglycemia and glucose excursions |
| 09/29/2010 | EP2231126A2 Oral dispersable tablet |
| 09/29/2010 | EP2231125A1 Manufacturing solid pharmaceutical dosage forms with visible micro-and nanostructured surfaces and micro-and nanostructured pharmaceutical dosage form |
| 09/29/2010 | EP2231124A1 Sustained-release pharmaceutical formulation containing an antimuscarinic agent and a wetting agent as well as a process for the preparation thereof |
| 09/29/2010 | EP2231123A2 Methods and compositions for oral administration of protein and peptide therapeutic agents |
| 09/29/2010 | EP2231122A1 Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release |
| 09/29/2010 | EP2231120A1 Solid lipid microcapsules containing growth hormone in the inner solid core |
| 09/29/2010 | EP2231119A1 Pharmaceutical foams |
| 09/29/2010 | EP2231118A2 Suspension comprising non-micronized ezetimibe micro-particles |
| 09/29/2010 | EP2231117A1 Benzodiazepine and/or pharmaceutical composition comprising benzodiazapine derivatives |
| 09/29/2010 | EP2231116A1 Pharmaceutical formulations containing tolperisone |
| 09/29/2010 | EP2231115A1 Transcutaneous pharmaceutical compositions containing a steroid hormone |
| 09/29/2010 | EP2231114A1 Composition for the treatment of a detached retina and method of production thereof |
| 09/29/2010 | EP2231113A2 Pharmaceutical compound for the prophylaxis and/or symptomatic treatment of cystic fibrosis |
| 09/29/2010 | EP2231112A1 Compressed chewing gum comprising sterol |
| 09/29/2010 | EP2230932A1 Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon |
| 09/29/2010 | EP2230911A1 Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs |
| 09/29/2010 | EP1962808B1 Hcv prodrug formulation |
| 09/29/2010 | EP1652535B1 Semi-solid mucoadhesive formulations |
| 09/29/2010 | EP1649864B1 Periodontal disease therapeutic and/or preventive composition |
| 09/29/2010 | EP1575670B1 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia |
| 09/29/2010 | EP1575569B1 Oral drug delivery system comprising high viscosity liquid carrier materials |
| 09/29/2010 | EP1505093B1 Hydrogel of (semi)interpenetrating network structure and process for producing the same |
| 09/29/2010 | EP1450847B1 APO2 ligand/ TRAIL formulations and uses thereof |
| 09/29/2010 | EP1425077B1 Azeotrope-like compositions of tetrafluoroethane, pentafluoropropane and water |
| 09/29/2010 | EP1413294B1 Composition comprising sustained-release fine particles for quick-disintegrating tablets in the buccal cavity |
| 09/29/2010 | EP1399411B1 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies |
| 09/29/2010 | CN201591849U Tizanidine hydrochloride scratch tablet |
| 09/29/2010 | CN201591848U Suppository and drug administration device |
| 09/29/2010 | CN1984640B Topical antiviral formulations |
| 09/29/2010 | CN1947754B Medicine for treating infantile asthma and its preparation method |
| 09/29/2010 | CN1927403B Medicine for promoting pigling growth and improving pigling immunity and preparing method thereof |
| 09/29/2010 | CN1919246B Traditional Chinese medicine for treating cardiovascular diseases |
| 09/29/2010 | CN1919239B Traditional medicine composition for treating cardiovascular and cerebrovascular diseases |
| 09/29/2010 | CN1919236B Medicine for treating cardiovascular and cerebrovascular diseases |
| 09/29/2010 | CN1899287B Slow release medicinal composition for treating anxiety and its preparing method |
| 09/29/2010 | CN1893919B Endoparasiticidal agents for topical application |
| 09/29/2010 | CN1883634B Preparation process of stomach-caring Chinese medicine with monkey head mushroom |
| 09/29/2010 | CN1872327B Composition of medicine for treating diarrhea |
| 09/29/2010 | CN1872285B Drop pills of Chinese traditional medicine, and preparation method |
| 09/29/2010 | CN1872261B Drop pills of fine powder of dragons blood, and preparation method |
| 09/29/2010 | CN1872250B Composition of medication for treating headache |
| 09/29/2010 | CN1872139B Drop pills for treating bronchitis |
| 09/29/2010 | CN1872111B Medication for treating cardiovascular diseases and cerebrovascular disease |
| 09/29/2010 | CN1872099B Medication for treating cardiovascular diseases, and cerebrovascular disease |
| 09/29/2010 | CN1872064B Drop pills of piperazine ferulic acid, and preparation method |
| 09/29/2010 | CN1872052B Drop pills of simvastatin, and preparation method |
| 09/29/2010 | CN1872040B Drop pills of sodium ferulic acid, and preparation method |
| 09/29/2010 | CN1872037B Drop pills of paeonol, and preparation method |
| 09/29/2010 | CN1868505B 蛇胆粉胶囊 Snake Powder Capsules |
| 09/29/2010 | CN1867580B Compound modified with glycerol derivative |
| 09/29/2010 | CN1864744B Pharmaceutical preparation containing urate oxidase |
| 09/29/2010 | CN1859943B System for controlling concentration of glucose in a patient |
| 09/29/2010 | CN1857515B Skin care Chinese medicine film preparation and its preparing process |
| 09/29/2010 | CN1814249B Chinese medicine composition for treating hepatitis and preparation method thereof |
| 09/29/2010 | CN1794974B 药物递送体系 Drug delivery system |
| 09/29/2010 | CN1778337B Preparation of compound Danshen Root tablet |
| 09/29/2010 | CN1679573B Implantable vascular device for delivery of topotecan in combination with rapamycin |
| 09/29/2010 | CN1674868B Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent |
| 09/29/2010 | CN1660064B Nage lieqin self-emulsifying system for releasing medicine |
| 09/29/2010 | CN1650845B High lipid content sprayable emulsions |
| 09/29/2010 | CN1475207B Solid oral dosage mode containing walshaden and hydrochloric thizaine |
| 09/29/2010 | CN101848739A Surgical hydrogel |
| 09/29/2010 | CN101848715A Two-component eye drops containing pirenoxine |
| 09/29/2010 | CN101848713A Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation |
| 09/29/2010 | CN101848707A Carrier particle for a microorganism or subunit thereof, pharmaceutical composition comprising such particles, method for preparation of this composition and its use in the treatment of animals |
| 09/29/2010 | CN101848706A Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinylalcohol |
| 09/29/2010 | CN101848705A Process for preparing clopidogrel compositions |
| 09/29/2010 | CN101848704A Technology for the preparation of microparticles |